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Risk analysisAbstract Background: Limited information is available about predictors of short-term outcomes
in patients with exacerbation of chronic obstructive pulmonary disease (eCOPD) attending an
emergency department (ED). Such information could help to stratify these patients and guide med-
ical decision-making. The aim of this study was to develop a clinical prediction rule for in-hospital
mortality of eCOPD.
Methods: The study was conducted on 100 consecutive adult patients, who were admitted to the
Emergency Medical Department in Alexandria Main University Hospital with the diagnosis of
eCOPD. Admission clinical data and in-hospital death rates were recorded. Independent predictors
of outcome were identiﬁed by logistic regression analysis and incorporated into a clinical prediction
tool.
Results: Most of parameters in the DECAF score (Dyspnea, Eosinopenia, Consolidation, respi-
ratory Acidosis and atrial Fibrillation) showed a statistically signiﬁcant value to the mortality;
dyspnea (p= 0.001), Consolidation (p= 0.030) and respiratory Acidosis (p< 0.001). Frequency
of admissions was found to be the most linked factor to mortality after eCOPD with a statisticallyd.
76 M.H. Zidan et al.signiﬁcant value (p< 0.001). The Modiﬁed DECAF score (Dyspnea, Eosinopenia, Consolidation,
respiratory Acidosis, Frequency of admissions) is more sensitive and speciﬁc in predicting in-hos-
pital mortality in eCOPD than the DECAF score.
Conclusion: The DECAF score is a powerful score to predict in-hospital mortality from eCOPD.
Most of the predictors in the score make sense as to why they might predict mortality in eCOPD,
meaning largely objective and reliable. The modiﬁed DECAF score is more sensitive and speciﬁc in
predicting in-hospital mortality in eCOPD than the DECAF score.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. All rights reserved.Table 1 The DECAF score.
Variable Points
Dyspnea limiting the patient to home (MRCD 5) and
Independent in bathing and/or dressing (eMRCD 5a) 1
Requires assistance with bathing and dressing (eMRCD 5b) 2
Eosinopenia (<0.05 · 10^9/L) 1
Consolidation (on chest X-ray) 1
Acidemia (pH< 7.30) 1
Atrial Fibrillation (on admission EKG) 1
Total score 6
Table 2 Distribution of the studied cases according to
demographic data.Introduction
COPD is a leading cause of morbidity and mortality world-
wide and results in an economic and social burden that is both
substantial and increasing [1,2].
An exacerbation of COPD is deﬁned as an acute event char-
acterized by a worsening of the patient’s respiratory symptoms
that is beyond normal day-to-day variations and leads to a
change in medication [3–5].
Identifying upon admission those at higher risk of dying
in-hospital could be useful for triaging patients to the
appropriate level of care, determining aggressiveness of ther-
apies, guiding goals-of-care discussions, and timing safe
discharges.
The objective of our study is to assess the prognostic effect
of the DECAF score in predicting hospital mortality in exacer-
bations of chronic obstructive pulmonary disease.
No. %
Sex
Male 58 58.0
Female 42 42.0
Age
20–40 38 38.0
41–60 47 47.0
>60 15 15.0
Min.–max. 27.0 – 81.0
Mean ± SD 46.46 ± 12.27
Median 44.0Subjects and methods
The study included 100 consecutive adult male and female
patients, who were admitted to the Emergency Medicine
Departments in Alexandria Main University Hospital with
the diagnosis of eCOPD. Inclusion criteria were; age more
than 25 years, smoking history of more than 10 cigarette pack
years, and admission from the primary residence. Exclusion
criteria were; domiciliary ventilation, comorbidity expected
to limit survival to <12 months (principally metastatic malig-
nancy), primary reason for admission other than eCOPD,
patients were managed at the discretion of their treating
physicians.
All patients included in the study were subjected on
admission to the following; complete history taking, complete
physical examination, complete chest examination and
assessment using the DECAF Score (Table 1).Results
Distribution of the studied cases according to demographic data
Among 100 studied patients with eCOPD, the age of studied
patients ranged from 27 to 81 years with a mean of
46.46 ± 12.27 years. There were 58 male patients who repre-
sented 58% of total studied cases and 42 female patients rep-
resented 42% of total studied cases (Table 2).Relationship between mortality and demographic data
There was a signiﬁcant relation between mortality and increas-
ing age of patients (p< 0.001) (Table 3).
Distribution of the studied cases according to frequent
admissions in last year
In our study, there were 40 cases who had no past medical his-
tory of previous admission in the last year in hospital; while
there were 25 cases who had past history of one admission in
the last year, 22 cases had past history of two admissions
in the last year, 6 cases were admitted to hospital three times
in the last year and 7 cases had past history of more than three
times of admission in the last year (Table 4).
Table 3 Relationship between mortality and demographic data.
Mortality Test of sig. p
No (n= 89) Yes (n= 11)
No. % No. %
Sex
Male 50 56.2 8 72.7 v2 = 1.100 FEp= 0.350
Female 39 43.8 3 27.3
Age
20–40 37 41.6 1 9.1 v2 = 16.348* MCp< 0.001*
41–60 44 49.4 3 27.3
>60 8 9.1 7 63.6
Min.–max. 27.0–730 35.0–81.0 t= 5.099 <0.001*
Mean ± SD 44.49 ± 10.77 62.36 ± 12.54
Median 43.0 64.0
Table 4 Distribution of the studied cases according to
frequent admissions in the last year.
No. %
Previous admission in one year
No 40 40.0
1 25 25.0
2 22 22.0
3 6 6.0
More than 3 times 7 7.0
Table 6 Distribution of the studied cases according to
DECAF score.
No. %
eMCD5
0 70 70.0
1 19 19.0
2 11 11.0
Eosinopenia
0 87 87.0
1 13 13.0
Consolidation
0 49 49.0
1 51 51.0
Acidemia
0 88 88.0
1 12 12.0
Atrial Fibrillation
0 88 88.0
1 12 12.0
Score
Min.–max. 0.0–6.0
Mean ± SD 1.30 ± 1.32
Median 1.0
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year
There is a signiﬁcant p value (p< 0.001) between increase in
frequency of admission and mortality rate in-hospital due to
Acute Exacerbation of COPD (Table 5).
Distribution of the studied cases according to DECAF score
Dyspnea
There were 70 cases who presented with dyspnea (eMRCD
0–4) with score 0, 19 cases presented with dyspnea (eMRCD
5a) with score 1, and 11 cases presented with dyspnea
(eMRCD 5b) with score 2 (Table 6).Table 5 Relation between mortality and frequent admission in the last year.
Mortality v2 MCp
No (n= 89) Yes (n= 11)
No. % No. %
Previous admission in one year
No 40 44.9 0 0.0 24.075* <0.001*
1 24 27.0 1 9.1
2 18 20.2 4 36.4
3 5 5.6 1 9.1
More than 3 times 2 2.2 5 45.5
Table 8 Distribution of the studied cases according to
Modiﬁed DECAF Score.
No. %
eMCD
0 70 70.0
1 19 19.0
2 11 11.0
Eosinopenia
0 87 87.0
1 13 13.0
Consolidation
0 49 49.0
1 51 51.0
Acidemia
0 88 88.0
1 12 12.0
Frequency of admission
0 65 65.0
1 35 35.0
Score
Min.–max. 0.0–6.0
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There were 87 cases whose eosinophilic count was
P0.05 · 10^9/L with score 0 and for 13 cases their eosinophilic
count was <0.05 · 10^9/L with score 1 (Table 6).
Consolidation
There were 49 cases whose X-ray did not show consolidation
with score 0, and in 51 cases their X-ray showed consolidation
with score 1 (Table 6).
Acidemia
There were 12 cases in our study with their ABG (Arterial
Blood Gas sample) showing Acidemia (pH< 7.30) with score
1 while the remaining cases were (pHP 7.30) with score 0
(Table 6).
Atrial Fibrillation
There were 12 cases with their ECG showing Atrial Fibrilla-
tion with score 1 while the remaining cases had their ECG
exclude Atrial Fibrillation with score 0 (Table 6).
The total score was from 0 to 6 with mean score of
1.30 ± 1.32 (Table 6).Mean ± SD 1.52 ± 1.62
Median 1.0Relationship between mortality and DECAF score
In our study we found the following: there was a statistically
signiﬁcant value (p= 0.001) between grade of dyspnea in the
DECAF score and in-hospital mortality of Acute Exacerba-
tion of COPD. There was also, a statistically signiﬁcant value
(p= 0.030) between the presence of consolidation in X-ray
of cases and in-hospital mortality of eCOPD. There is aTable 7 Relationship between mortality and DECAF score.
Mortality
No (n= 89) Yes (n=
No. % No.
eMCD
0 67 75.3 3
1 16 18.0 3
2 6 6.7 5
Eosinopenia
0 78 87.6 9
1 11 12.4 2
Consolidation
0 47 52.8 2
1 42 47.2 9
Acidemia
0 85 95.5 3
1 4 4.5 8
Atrial Fibrillation
0 79 88.8 9
1 10 11.2 2
Score
Min.–max. 0.0–5.0 1.0–5.0
Mean ± SD. 1.08 ± 1.11 5.0 ± 3.0
Median 1.0 3.0signiﬁcant value (p< 0.001) between respiratory acidosis
(pH < 7.30) which is present in the ABG of some cases and
in-hospital mortality rate (Table 7).
The total DECAF score showed a statistically signiﬁcant
value (p< 0.001) in relation to the in-hospital mortality of
Acute Exacerbation of COPD (Table 7).Test of sig. P
11)
%
27.3 v2 = 13.310* MCP= 0.001*
27.3
45.5
81.8 v2 = 0.293 FEp= 0.633
18.2
18.2 v2 = 4.697* 0.030*
81.8
27.3 v2 = 43.162* FEp< 0.001*
72.7
81.8 v2 = 0.447 FEp= 0.618
18.2
Z= 3.910* <0.001*
9
Table 9 Relationship between mortality and Modiﬁed DECAF score.
Mortality Test of sig. P
No (n= 89) Yes (n= 11)
No. % No. %
eMCD
0 67 75.3 3 27.3 v2 = 13.310* MCP= 0.001*
1 16 18.0 3 27.3
2 6 6.7 5 45.5
Eosinopenia
0 78 87.6 9 81.8 v2 = 0.293 FEp= 0.633
1 11 12.4 2 18.2
Consolidation
0 47 52.8 2 18.2 v2 = 4.697* 0.030*
1 42 47.2 9 81.8
Acidemia
0 85 95.5 3 27.3 v2 = 43.162* FEp< 0.001*
1 4 4.5 8 72.7
Frequency of admission
0 64 71.9 1 9.1 v2 = 16.982* FEp< 0.001*
1 25 28.1 10 90.0
Score
Min.–max. 0.0–5.0 1.0–6.0 Z= 4.180* <0.001*
Mean ± SD 1.24 ± 1.37 3.82 ± 1.72
Median 1.0 4.0
AUC p
DECAF Score 0.848* <0.001
Modified 0.874* <0.001
Figure 1 Comparison between the DECAF score and the
modiﬁed DECAF score.
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score
Frequency of admission: there were 65 cases who had past his-
tory with less than 2 times of previous admission in the last
year by Acute Exacerbation of COPD with score 0. There were
35 cases who had past history with more than or equal to 2
times of admission in the last year with score 1 (Table 8).
The total score was from 0 to 6 with a mean of 1.52 ± 1.62
score (Table 8).
The other items of the score similar like in the (Table 6).
Relationship between mortality and modiﬁed DECAF score
There were statistically signiﬁcant values (p< 0.001) between
the frequency of admission and in-hospital mortality due to
eCOPD. There were signiﬁcant values (p< 0.001) between
the modiﬁed DECAF score and in-hospital mortality due to
eCOPD (Table 9).
The relation between other items in the modiﬁed DECAF
score is similar to the same items in DECAF score (Table 7).
Comparison between the DECAF score and the modiﬁed
DECAF score
The DECAF score in comparison with the modiﬁed DECAF
score in our study: we found the modiﬁed DECAF score is
more sensitive and more speciﬁc in predicting in-hospital
mortality in Acute Exacerbation of COPD than the DECAF
score with no signiﬁcant difference between the two scores
(Fig. 1).Discussion
The age of studied patients ranged from 27 to 81 years with a
mean of 46.46 ± 12.27 years. And, ‘‘there was a statistical dif-
ference as regards age with a p value that equals =<0.001’’.
This was in agreement with John Steer et al. who studied the
DECAF score in predicting hospital mortality in Acute Exac-
80 M.H. Zidan et al.erbation of COPD on 920 patients in 2 major hospitals in the
UK, who were showing a signiﬁcant relation between increase
in age and the mortality rate [6].
In this current study it was obviously observed that; there is
a signiﬁcant p value (equals =<0.001) between increase in
frequency of admission and mortality rate in hospital due to
Acute Exacerbation of COPD. As in Hurst et al., who studied
the susceptibility to exacerbation in chronic obstructive pul-
monary disease the best predictor of having frequent exacerba-
tions (2 or more exacerbations per year) is a history of
previously treated events [7].
The total DECAF score showed a statistically signiﬁcant
value (p< 0.001) in relation to the in-hospital mortality of
Acute Exacerbation of COPD. In comparison with John Steer
et al., a major study was done in 920 cases of COPD exacerba-
tion in 2 major hospitals in the UK [6]: There was an agree-
ment in the DECAF score as a signiﬁcant predictor of Acute
Exacerbation of COPD.
During the study we tried to replace atrial Fibrillation item
in the score (which has no signiﬁcant value (p= 0.618)) to
mortality by the frequency of admission (which has a signiﬁ-
cant relation to the mortality (p< 0.001)), and we called the
new score Modiﬁed DECAF score (Dyspnea, Eosinopenia,
Consolidation, respiratory Acidosis and Frequency of admis-
sion). There were signiﬁcant values (p< 0.001) between the
modiﬁed DECAF score and mortality due to eCOPD. The
Modiﬁed DECAF score is more sensitive and more speciﬁc
in predicting in-hospital mortality in Acute Exacerbation of
COPD than the DECAF score with no signiﬁcant difference
between the two scores (Fig. 1).
In summary, Mortality from COPD Exacerbations was
observed to be increasing with age. The DECAF score
(Dyspnea, Eosinopenia, Consolidation, respiratory Acidosis
and atrial Fibrillation) is a powerful score to predict inhospital mortality from COPD exacerbation. Most of the
predictors in the DECAF score make sense as to why they
might predict mortality in AECOPD, meaning they carry ‘‘face
validity’’ and they are largely objective and reliable. Frequency
of admissions was found to be the most linked factor to
mortality after COPD exacerbations. The DECAF score in
comparison with the Modiﬁed DECAF score (Dyspnea,
Eosinopenia, Consolidation, respiratory Acidosis and
Frequency of admission); the Modiﬁed DECAF score is more
sensitive and more speciﬁc in predicting in hospital mortality
in Acute Exacerbation of COPD than the DECAF score.
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